Vascular Endothelial Growth Factor Protein Expression Is Associated With A Poor Prognosis In Patients With Cutaneous Extranodal Natural Killer/T-Cell Lymphoma

Vascular endothelial growth factor (VEGF) can stimulate angiogenesis and lymphangiogenesis, which are crucial processes in the growth and metastasis of tumour cells.1,2 The immunohistochemical status of VEGF protein expression in tumour tissue of extranodal NK/T-cell lymphoma (ENKTL) has not yet been evaluated. Herein, we investigated VEGF protein expression, as well as its prognostic value in cutaneous ENKTL patients.This article is protected by copyright. All rights reserved.